drugset / Trial / NCT01333332

Radiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas Cancer

NCT01333332 ↗

Phase 2 Unknown 35 enrolled University of Virginia
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine safety and to obtain preliminary estimates of the rate of major pathologic response of neoadjuvant accelerated fraction, standard dose radiation given with chemotherapy in patients with locally advanced pancreas cancer.

Timeline

Start
2010-08
Primary completion
2012-08
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Capecitabine Small molecule — —